BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 114012
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114012
Table 3 Weighted baseline characteristics by quartiles of the Ferritin index
Ferritin index
Quartile 1 (1.89-83.13)
Quartile 2 (83.18-129.21)
Quartile 3 (130.65-175.25)
Quartile 4 (175.68-378.29)
Statistic
P value
Age44.31 ± 10.5145.90 ± 11.0146.95 ± 9.4647.66 ± 8.70F = 1.940.122
TAM92.71 ± 11.7196.23 ± 14.1090.62 ± 11.2291.41 ± 14.77F = 0.560.645
TSGF52.11 ± 15.9452.25 ± 18.3351.70 ± 17.9854.60 ± 18.68F = 0.420.736
AST22.16 ± 7.3423.52 ± 26.2523.61 ± 9.1523.78 ± 14.54F = 0.190.902
ALT22.07 ± 13.3329.38 ± 55.1627.47 ± 18.3527.73 ± 23.93F = 0.880.453
ALP75.24 ± 35.5275.57 ± 23.0474.70 ± 17.4483.76 ± 42.89F = 1.470.222
LDH175.75 ± 46.90167.67 ± 45.76173.61 ± 40.56179.49 ± 51.28F = 0.930.428
GGT27.34 ± 25.4136.67 ± 50.4237.54 ± 39.9254.94 ± 146.71F = 1.630.182
5-NT5.66 ± 4.426.24 ± 5.186.39 ± 4.826.94 ± 7.87F = 0.670.571
GPDA70.79 ± 20.3765.42 ± 25.2272.53 ± 23.0374.70 ± 28.84F = 2.110.099
ADA13.85 ± 7.5115.42 ± 14.5116.90 ± 18.8813.91 ± 9.46F = 0.930.426
MAO4.71 ± 2.504.78 ± 2.005.30 ± 2.585.12 ± 2.72F = 1.020.385
NSE2.07 ± 1.302.64 ± 1.612.88 ± 2.082.88 ± 2.51F = 3.550.015a
CEA1.13 ± 0.791.57 ± 2.221.36 ± 1.071.58 ± 1.43F = 1.910.127
AFP1.28 ± 1.131.94 ± 2.912.01 ± 2.121.71 ± 1.76F = 2.290.078
Tumor stage (%)-0.838
    I0000
    II5.066.104.945.13
    III54.4354.8854.3242.31
    IVa36.7134.1535.8043.59
    IVb3.804.884.948.97
Gender (%)χ² = 44.94< 0.001a
    Male41.7676.9282.4276.92
    Female58.2423.0817.5823.08
3-year survivors (%)χ² = 34.13< 0.001a
    Death3.3029.6731.8738.46
    Survival96.7070.3368.1361.54
5-year survivors (%)χ² = 97.78< 0.001a
    Death8.7962.6457.1478.02
    Survival91.2137.3642.8621.98


Write to the Help Desk